Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C A Meier

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Journal of Endocrinological Investigation|November 1, 1995
Quantitation of beta 1 triiodothyronine receptor mRNA in human tissues by competitive reverse transcription polymerase chain reactionS Meier-Heusler, A Pernin, H Liang, et al.
The Journal of Biological Chemistry|October 6, 1997
DNA binding properties of peroxisome proliferator-activated receptor subtypes on various natural peroxisome proliferator response elements. Importance of the 5'-flanking regionC Juge-Aubry, A Pernin, T Favez, et al.
The Journal of Biological Chemistry|July 28, 1995
Peroxisome proliferator-activated receptor mediates cross-talk with thyroid hormone receptor by competition for retinoid X receptor. Possible role of a leucine zipper-like heptad repeatC E Juge-Aubry, A Gorla-Bajszczak, A Pernin, et al.
Endocrinology|October 1, 1996
The peroxisome proliferator-activated receptor alpha is a phosphoprotein: regulation by insulinA Shalev, C A Siegrist-Kaiser, P M Yen, et al.
Molecular and Cellular Endocrinology|January 1, 1995
Modulation of thyroid hormone action by mutant thyroid hormone receptors, c-erbA alpha 2 and peroxisome proliferator-activated receptor: evidence for different mechanisms of inhibitionS C Meier-Heusler, X Zhu, C Juge-Aubry, et al.
Annales De Chirurgie|January 24, 2002
[Thyroid cancers: the Geneva experience]F Triponez, S Simon, J Robert, et al.
The Journal of Clinical Investigation|October 1, 1993
Interaction of human beta 1 thyroid hormone receptor and its mutants with DNA and retinoid X receptor beta. T3 response element-dependent dominant negative potencyC A Meier, C Parkison, A Chen, et al.
Diabetes & Metabolism|February 5, 2008
Gender-based dimorphic pattern for interleukin-1 receptor antagonist in type 2 diabetes mellitusJ Ybarra, T N O Lehmann, A Golay, et al.
Diabetologia|March 10, 2005
Hypothyroidism in rats decreases peripheral glucose utilisation, a defect partially corrected by central leptin infusionP Cettour-Rose, C Theander-Carrillo, C Asensio, et al.
The Journal of Biological Chemistry|April 3, 1999
Regulation of the transcriptional activity of the peroxisome proliferator-activated receptor alpha by phosphorylation of a ligand-independent trans-activating domainC E Juge-Aubry, E Hammar, C Siegrist-Kaiser, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Journal of Endocrinological Investigation|November 1, 1995
Quantitation of beta 1 triiodothyronine receptor mRNA in human tissues by competitive reverse transcription polymerase chain reactionS Meier-Heusler, A Pernin, H Liang, et al.
The Journal of Biological Chemistry|October 6, 1997
DNA binding properties of peroxisome proliferator-activated receptor subtypes on various natural peroxisome proliferator response elements. Importance of the 5'-flanking regionC Juge-Aubry, A Pernin, T Favez, et al.
The Journal of Biological Chemistry|July 28, 1995
Peroxisome proliferator-activated receptor mediates cross-talk with thyroid hormone receptor by competition for retinoid X receptor. Possible role of a leucine zipper-like heptad repeatC E Juge-Aubry, A Gorla-Bajszczak, A Pernin, et al.
Endocrinology|October 1, 1996
The peroxisome proliferator-activated receptor alpha is a phosphoprotein: regulation by insulinA Shalev, C A Siegrist-Kaiser, P M Yen, et al.
Molecular and Cellular Endocrinology|January 1, 1995
Modulation of thyroid hormone action by mutant thyroid hormone receptors, c-erbA alpha 2 and peroxisome proliferator-activated receptor: evidence for different mechanisms of inhibitionS C Meier-Heusler, X Zhu, C Juge-Aubry, et al.
Annales De Chirurgie|January 24, 2002
[Thyroid cancers: the Geneva experience]F Triponez, S Simon, J Robert, et al.
The Journal of Clinical Investigation|October 1, 1993
Interaction of human beta 1 thyroid hormone receptor and its mutants with DNA and retinoid X receptor beta. T3 response element-dependent dominant negative potencyC A Meier, C Parkison, A Chen, et al.
Diabetes & Metabolism|February 5, 2008
Gender-based dimorphic pattern for interleukin-1 receptor antagonist in type 2 diabetes mellitusJ Ybarra, T N O Lehmann, A Golay, et al.
Diabetologia|March 10, 2005
Hypothyroidism in rats decreases peripheral glucose utilisation, a defect partially corrected by central leptin infusionP Cettour-Rose, C Theander-Carrillo, C Asensio, et al.
The Journal of Biological Chemistry|April 3, 1999
Regulation of the transcriptional activity of the peroxisome proliferator-activated receptor alpha by phosphorylation of a ligand-independent trans-activating domainC E Juge-Aubry, E Hammar, C Siegrist-Kaiser, et al.
Pageof 6